Compare Edwards Lifesciences Corporation Common Stock (EW) vs Progressive Corp (PGR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Progressive Corp — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.25 (market cap $48.56B), while Progressive Corp trades at $217.5 (market cap $126.95B). The key difference: Progressive Corp is far larger — about 2.6× Edwards Lifesciences Corporation Common Stock's market cap, and Progressive Corp pays a 0.18% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | PGR | |
|---|---|---|
Market Cap | $48.56B | $126.95B |
Volume | 6,520,488 | 2,749,438 |
Sector | Health | Financials |
52-Week High | $95.18 | $242.16 |
52-Week Low | $72.65 | $190.40 |
Enterprise Value | $45.01B | $135.16B |
Typical Hold Time | — | 81 Days |
Dividend Yield | — | 0.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Progressive Corporation (PGR) trades at $218.51, up 2.05% with strong technical momentum and bullish moving average signals. The stock shows robust fundamentals with 12.85% net income margin and 34.94% ROE, supported by consistent revenue growth from $49.6B in 2022 to $87.6B in 2025. Recent earnings beat expectations in Q2 2026 with EPS of $4.85 versus $4.64 expected, though Q1 2026 slightly missed. Analyst consensus price target is $222.23 with 38.1% buy ratings.
PGR presents a favorable risk-reward profile with upside to consensus targets, though near-term overbought RSI conditions warrant caution. The insurance giant's telematics advantage and underwriting discipline provide competitive moat, while intensifying auto insurance competition represents the primary business risk. Current valuation at 10.97 P/E appears reasonable given growth trajectory and profitability metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Progressive Corp
Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →
